mist: molecularly targeted therapy for malignant pleural mesothelioma
Published 5 years ago • 824 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
1:43
mesomics: molecular characterization of malignant pleural mesothelioma
-
0:56
targeting the tumor vasculature in mesothelioma
-
8:21
mist: personalized approaches to mesothelioma treatment
-
2:39
mist: parp inhibitors for malignant mesothelioma
-
1:11
oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma
-
5:36
systems-2: higher dose of radiotherapy increases life expectancy for malignant pleural mesothelioma
-
1:35
cutting-edge uk trials for mesothelioma: double immuno, arginine depletion and molecular profiling
-
2:28
a morphomolecular classification of malignant pleural mesothelioma
-
2:12
atomic-meso: pegargiminase in malignant pleural mesothelioma
-
3:05
therapeutic targets for mesothelioma and sarcomatoid carcinoma
-
25:57
systemic therapy for malignant pleural mesothelioma
-
1:08
arginine deprivation therapy in mesothelioma
-
1:34
phase 1b trial of crs-207 with chemotherapy for malignant pleural mesothelioma
-
34:46
the role of surgery in malignant pleural mesothelioma - harvey pass, md
-
3:33
immunotherapy for mesothelioma
-
3:34
role of immunotherapy in the management of mesothelioma
-
3:40
pembrolizumab showed clinical benefit in malignant pleural mesothelioma
-
6:19
emerging options for malignant pleural mesothelioma
-
5:27
treatment of unresectable malignant pleural mesothelioma in 2021:emerging standards in immunotherapy